Bartlett & Co Wealth Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
Bartlett & Co Wealth Management's DXCM Position: Q2 2026 in Review
Bartlett & Co Wealth Management increased its DexCom (DXCM) stake by 2,020% in Q2 2026, buying an estimated $6.73K and bringing the position to 106 shares worth $7.14K. The position accounts for ﹤0.01% of the portfolio, ranked #1041.
Bartlett & Co Wealth Management first reported a position in DXCM in Q4 2020 and has held it in 17 quarters since. The position peaked at $26.7K in Q4 2023. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Bartlett & Co Wealth Management held 106 shares of DexCom worth $7.14K as of Q2 2026.
- Bartlett & Co Wealth Management bought 101 DexCom shares in Q2 2026, an estimated $6.73K.
- DexCom made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q2 2026, its #1041 holding.
- Bartlett & Co Wealth Management first reported a position in DexCom in Q4 2020 and has held it in 17 quarters since.
- Bartlett & Co Wealth Management's DexCom position peaked at $26.7K in Q4 2023.
- 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Bartlett & Co Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.